Premium
Incidental adenocarcinoma of the prostate: The role of repeat transurethral resection in staging
Author(s) -
Paul Sonda L.,
Barton Grossman H.,
MacGregor Robert J,
Gikas Paul W.
Publication year - 1984
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.2990050203
Subject(s) - medicine , prostate , adenocarcinoma , transurethral resection of the prostate , resection , prostatic adenocarcinoma , prostate disease , urology , prostate cancer , radiology , surgery , cancer
Accurate staging of patients with incidental prostatic adenocarcinoma (A 1 vs A 2 ) is crucial to the selection of appropriate treatment. To evaluate the potential sampling error in specimens obtained by transurethral resection, repeat resection was performed on 31 patients pathologically staged as A 1 (five or less chips with tumor). Second specimens showed no tumor in 22 (71 %), stage A 1 in six (20%), and stage A 2 in three (9%). The weight of tissue removed at reresection was greater in patients found to have more extensive involvement (P < 0.005). No patient with initial Gleason score 2, 3, or 4 had stage A 2 at reresection. Repeat resection is not routinely necessary, but may be helpful when the tumor is high grade but of minimal extent, in an anxious younger patient who may wish therapy if disease persists, or where some suspicion of an incomplete resection exists.